Skip to content
HomeLatest newsJohnson & Johnson named a 2018 Fortune World’s Most Admired Company
Lede- Fortune Most Admired Company- Businesswoman

Johnson & Johnson named a 2018 Fortune World’s Most Admired Company

The company has once again been recognized for its commitment to employees, innovation and the health and well-being of people around the world.

What does it take to be a Fortune World’s Most Admired Company?

It comes down to three key attributes: forward-thinking business practices, smart management and social responsibility.

And that’s something Johnson & Johnson has in spades, given that, for the 16th year in a row, the company has nabbed a spot on the respected Fortune list, appearing in the top 20. Johnson & Johnson also placed #1 in the Pharmaceutical category worldwide for the fifth consecutive year—making it the highest-ranked healthcare company to appear on the top companies list in 2018.

The company’s top industry ranking was determined by such key attributes of reputation as its people management and overall quality of management, social responsibility, financial soundness, long-term investment value and global competitiveness.

A World’s Most Admired Company in action

As any of the company’s 130,000+ employees can tell you, there’s a lot that makes Johnson & Johnson stand out.

For one, the company has put its commitment to advancing worldwide healthcare innovations front and center with initiatives like the Health for Humanity 2020 Goals and the GenH Challenge, a global social venture competition the company launched in 2017 aimed at finding possible solutions for some of today’s toughest health problems—like infectious disease and maternal/infant mortality—in order to help create the healthiest future generations ever.

A significant part of elevating the state of healthcare for generations to come is to also stay one step ahead of potential threats, which Johnson & Johnson is doing through its participation in the Coalition for Epidemic Preparedness Innovations (CEPI) that’s focused on helping fast-track vaccine development for known pathogens before they pose a major, widespread risk.

It all comes back to Our Credo, which outlines Johnson & Johnson’s mission to put the needs of all people—around the globe, across the U.S. and right in the company’s offices—first.

Another example of the company’s commitment to cutting-edge healthcare advances: the Center for Device Innovation at Texas Medical Center, a state-of-the-art facility designed to revolutionize medical device innovation that debuted in November 2017.

Johnson & Johnson has also made commitments to important human rights issues, both in the U.S. and globally. In 2017, the company made a $1 million donation to Save the Children to help support victims of Hurricanes Harvey, Irma and Maria. And since 2013, Johnson & Johnson has partnered with the United Nations Foundation to support the annual Global Moms Relay to help raise awareness of critical issues facing children and families.

Giving back closer to home—that is, directly to its employees—has been a point of pride for the company, too. For example, Johnson & Johnson expanded its military benefits in 2017, which now provide service member employees with their full salary while deployed, in addition to what the military pays them.

It all comes back to Our Credo, which outlines Johnson & Johnson’s mission to put the needs of all people—around the globe, across the U.S. and right in the company’s offices—first. Johnson & Johnson is honored that Fortune has recognized its leadership as a most admired company.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.